1. 1) Abelson MB, McLaughlin JT, Gomes PJ. Antihistamines in ocular allergy: are they all created equal? Curr. Allergy Asthma Rep., 11, 205–211 (2011).
2. 2) Inagaki N, Nakamura N, Nagao M, Musoh K, Kawasaki H, Nagai H. Participation of histamine H1 and H2 receptors in passive cutaneous anaphylaxis-induced scratching behavior in ICR mice. Eur. J. Pharmacol., 367, 361–371 (1999).
3. 3) Andoh T, Sakai K, Urashima M, Kitazawa K, Honma A, Kuraishi Y. Involvement of leukotriene B4 in itching in a mouse model of ocular allergy. Exp. Eye Res., 98, 97–103 (2012).
4. 4) Inami Y, Andoh T, Sasaki A, Kuraishi Y. Topical surfactant-induced pruritus: involvement of histamine released from epidermal keratinocytes. J. Pharmacol. Exp. Ther., 344, 459–466 (2013).
5. 5) Inami Y, Andoh T, Kuraishi Y. Prevention of topical surfactant-induced itch-related responses by chlorogenic acid through the inhibition of increased histamine production in the epidermis. J. Pharmacol. Sci., 121, 242–245 (2013).